These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 11887837)

  • 1. Undertreatment of cardiac risk factors in adolescents with renal failure.
    Querfeld U
    Perit Dial Int; 2001; 21 Suppl 3():S285-9. PubMed ID: 11887837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Approaches to the reversal of malnutrition, inflammation, and atherosclerosis in end-stage renal disease.
    Caglar K; Hakim RM; Ikizler TA
    Nutr Rev; 2002 Nov; 60(11):378-87. PubMed ID: 12462522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atherosclerosis in chronic renal failure.
    Charney DI; Walton DF; Cheung AK
    Curr Opin Nephrol Hypertens; 1993 Nov; 2(6):876-82. PubMed ID: 7922227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cardiovascular risk in patients with chronic renal failure. Patients in renal replacement therapy].
    Cases A; Vera M; López Gómez JM
    Nefrologia; 2002; 22 Suppl 1():68-74. PubMed ID: 11987673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The clinical significance of vascular calcification in young patients with end-stage renal disease.
    Querfeld U
    Pediatr Nephrol; 2004 May; 19(5):478-84. PubMed ID: 15015069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Addressing cardiovascular disease in patients with renal disease.
    Crook ED; Washington DO
    Ethn Dis; 2002; 12(4):S3-1-4. PubMed ID: 12477146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hypertension, dyslipidemia and cardiovascular risk in chronic renal disease].
    Ravera M; Paoletti E
    Ital Heart J Suppl; 2004 Jun; 5(6):436-44. PubMed ID: 15471148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular disease determinants in chronic renal failure: clinical approach and treatment.
    Locatelli F; Bommer J; London GM; Martín-Malo A; Wanner C; Yaqoob M; Zoccali C
    Nephrol Dial Transplant; 2001 Mar; 16(3):459-68. PubMed ID: 11239016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular disease in end stage renal disease.
    Sharma R; Pellerin D; Brecker SJ
    Minerva Urol Nefrol; 2006 Jun; 58(2):117-31. PubMed ID: 16767066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cardioprotection: an essential component for predialysis chronic renal failure treatment].
    Jungers P; Qualim Z; Nguyen-Khoa T; Massy Z; London G
    Nephrologie; 2003; 24(2):79-88. PubMed ID: 12723513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of nutrition for cardiovascular risk reduction in chronic kidney disease patients.
    Ikizler TA
    Adv Chronic Kidney Dis; 2004 Apr; 11(2):162-71. PubMed ID: 15216487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Risk factors and cardiovascular disease in uremic patients].
    Valdés F; Morales JM
    Nefrologia; 2002; 22 Suppl 4():1-6. PubMed ID: 12123136
    [No Abstract]   [Full Text] [Related]  

  • 13. Abnormalities in uremic lipoprotein metabolism and its impact on cardiovascular disease.
    Quaschning T; Krane V; Metzger T; Wanner C
    Am J Kidney Dis; 2001 Oct; 38(4 Suppl 1):S14-9. PubMed ID: 11576915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Lipid anomalies during renal insufficiency: consequences on the progression of renal insufficiency and cardiovascular risk].
    Moulin B
    Nephrologie; 2000; 21(7):339-41. PubMed ID: 11200605
    [No Abstract]   [Full Text] [Related]  

  • 15. Uremic toxins: some thoughts on acrolein and spermine.
    Sindhu KK
    Ren Fail; 2016 Nov; 38(10):1755-1758. PubMed ID: 27758122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Excess cardiovascular mortality in the uremic patient--what does it teach for other risk factors in the non-renal patient?
    Ritz E; Nowicki M; Wiecek A
    Pol Arch Med Wewn; 1994; 92 Spec No():110-6. PubMed ID: 7731891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disorders of carbohydrate and lipid metabolism in uremia.
    Bagdade
    Nephron; 1975; 14(2):153-62. PubMed ID: 1093054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular risk factors and their management in patients on continuous ambulatory peritoneal dialysis.
    Lameire N; Bernaert P; Lambert MC; Vijt D
    Kidney Int Suppl; 1994 Dec; 48():S31-8. PubMed ID: 7700039
    [No Abstract]   [Full Text] [Related]  

  • 19. Cause and management of heart failure in patients with chronic renal disease.
    Al-Ahmad A; Sarnak MJ; Salem DN; Konstam MA
    Semin Nephrol; 2001 Jan; 21(1):3-12. PubMed ID: 11172554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Atherosclerosis and uremia: signifance of non-traditional risk factors].
    Hörl WH
    Wien Klin Wochenschr; 2003 Apr; 115(7-8):220-34. PubMed ID: 12778774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.